122 related articles for article (PubMed ID: 20690664)
1. Serum and urinary metabonomic study of human osteosarcoma.
Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
3. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
[TBL] [Abstract][Full Text] [Related]
5. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
6. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.
Li ZF; Wang J; Huang C; Zhang S; Yang J; Jiang A; Zhou R; Pan D
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2765-75. PubMed ID: 20814984
[TBL] [Abstract][Full Text] [Related]
7. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
9. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
Teul J; Rupérez FJ; Garcia A; Vaysse J; Balayssac S; Gilard V; Malet-Martino M; Martin-Ventura JL; Blanco-Colio LM; Tuñón J; Egido J; Barbas C
J Proteome Res; 2009 Dec; 8(12):5580-9. PubMed ID: 19813770
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study.
Wong IH; Chan AT; Johnson PJ
Clin Cancer Res; 2000 Jun; 6(6):2183-8. PubMed ID: 10873067
[TBL] [Abstract][Full Text] [Related]
11. Pyridinoline cross-links as markers for primary and secondary bone tumors.
Behrens P; Bruns J; Ullrich KP; Açil Y; Gille J
Scand J Clin Lab Invest; 2003; 63(1):37-44. PubMed ID: 12729068
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
13. Dynamic metabolic transformation in tumor invasion and metastasis in mice with LM-8 osteosarcoma cell transplantation.
Hua Y; Qiu Y; Zhao A; Wang X; Chen T; Zhang Z; Chi Y; Li Q; Sun W; Li G; Cai Z; Zhou Z; Jia W
J Proteome Res; 2011 Aug; 10(8):3513-21. PubMed ID: 21661735
[TBL] [Abstract][Full Text] [Related]
14. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
15. [Detection of serum biomakers of osteosarcoma by proteomic profiling].
Shen JN; Jin S; Wang J; Huang G; Yin JQ; Guo QC; Li HM; Liu W; Liu SJ; Li MT
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):519-22. PubMed ID: 19062719
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training.
Yan B; A J; Wang G; Lu H; Huang X; Liu Y; Zha W; Hao H; Zhang Y; Liu L; Gu S; Huang Q; Zheng Y; Sun J
J Appl Physiol (1985); 2009 Feb; 106(2):531-8. PubMed ID: 19036890
[TBL] [Abstract][Full Text] [Related]
17. [1H-MRS metabonomic analysis of plasma samples of esophageal cancer patients based on different pattern recognition].
Ayshamgul H; Batur M; Ilyar S
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):681-4. PubMed ID: 21122383
[TBL] [Abstract][Full Text] [Related]
18. [Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].
Ma YL; Liu WJ; Peng JY; Zhang P; Chen HQ; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):386-90. PubMed ID: 19598026
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients.
Wang X; Wang X; Xie G; Zhou M; Yu H; Lin Y; Du G; Luo G; Jia W; Liu P
J Proteome Res; 2012 Jul; 11(7):3838-47. PubMed ID: 22624806
[TBL] [Abstract][Full Text] [Related]
20. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
